Retatrutide × VANDL Labs - Lab Test, March 2026
Test results
About this test
This independent HPLC-UV/VIS lab test confirms Retatrutide 100mg from VANDL Labs at 99.80% purity. Multiple vial analysis measured 114.17 mg (highest individual vial result), conducted by Vanguard Laboratory on March 30, 2026.
Retatrutide is a triple GLP-1/GIP/GCG receptor agonist researched for metabolic regulation, weight management, glycemic control, and glucose homeostasis. It is studied for its synergistic effects on multiple signaling pathways for comprehensive metabolic and anti-aging effects. The 99.80% purity indicates high-quality synthesis with minimal contamination.
The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.